Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes

G Boriani, M Vitolo, I Diemberger… - Cardiovascular …, 2021 - academic.oup.com
Atrial fibrillation (AF) has heterogeneous patterns of presentation concerning symptoms,
duration of episodes, AF burden, and the tendency to progress towards the terminal step of …

Stroke, major bleeding, and mortality outcomes in warfarin users with atrial fibrillation and chronic kidney disease: a meta-analysis of observational studies

K Dahal, S Kunwar, J Rijal, P Schulman, J Lee - Chest, 2016 - Elsevier
Background The use of warfarin in patients with atrial fibrillation (AF) and chronic kidney
disease (CKD) can be problematic because of increased bleeding risk. We performed a …

Chronic kidney disease and arrhythmias: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference

MP Turakhia, PJ Blankestijn, JJ Carrero… - European heart …, 2018 - academic.oup.com
Patients with chronic kidney disease (CKD) are predisposed to heart rhythm disorders,
including atrial fibrillation (AF)/atrial flutter, supraventricular tachycardias, ventricular …

Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis

KE Chan, ER Edelman, JB Wenger, RI Thadhani… - Circulation, 2015 - Am Heart Assoc
Background—Dabigatran and rivaroxaban are new oral anticoagulants that are eliminated
through the kidneys. Their use in dialysis patients is discouraged because these drugs can …

[HTML][HTML] 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation

CE Chiang, K Okumura, S Zhang, TF Chao, CW Siu… - Journal of arrhythmia, 2017 - Elsevier
Atrial fibrillation (AF) is the most common sustained arrhythmia, causing a 2-fold increase in
mortality and a 5-fold increase in stroke. The Asian population is rapidly aging, and in 2050 …

Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a …

G Boriani, I Savelieva, GA Dan, JC Deharo… - Ep …, 2015 - academic.oup.com
The kidney exerts multiple functions, and pathophysiological interactions between the
kidney and the heart have important clinical implications, but it has only recently become …

Atrial fibrillation and thromboembolism in patients with chronic kidney disease

YC Lau, M Proietti, E Guiducci, AD Blann… - Journal of the American …, 2016 - jacc.org
A bidirectional relationship exists between atrial fibrillation (AF) and chronic renal disease.
Patients with AF have a higher incidence of renal dysfunction, and the latter predisposes to …

Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: A systematic review and meta-analysis

H Van Der Meersch, D De Bacquer, AS De Vriese - American heart journal, 2017 - Elsevier
Background The use of vitamin K antagonists (VKAs) in hemodialysis patients with atrial
fibrillation (AF) is controversial. No randomized trials are available and observational studies …

Management of atrial fibrillation: Two decades of progress—A scientific statement from the European Cardiac Arrhythmia Society

S Lévy, G Steinbeck, L Santini, M Nabauer… - Journal of Interventional …, 2022 - Springer
Background Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in
clinical practice. The aim of this review was to evaluate the progress made in the …

Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis

J Tan, S Liu, JB Segal, GC Alexander… - BMC nephrology, 2016 - Springer
Background Patients with end stage renal disease (ESRD), including stage 5 chronic kidney
disease (CKD), hemodialysis (HD) and peritoneal dialysis (PD), are at high risk for stroke …